CLINICAL_TRIALS
trial_result
· 2022-01-31
Clinical Trial Update: Pharmacokinetics and Metabolism of 14 Carbon [14C]-GSK3640254 [Phase 1]
Summary
Phase 1 pharmacokinetics and metabolism study of 14C-labeled GSK3640254 completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2022-01-31